Determinants of resource utilization in the treatment of brain arteriovenous malformations

American Journal of Neuroradiology

Volumn 20, Issue 10, 1999, Pages 2004-2008

  Berman, Mitchell F ^a,d   Hartmann, Andreas ^a,b   Mast, Henning ^a,b,c   Sciacca, Robert R ^a   Mohr, J P ^a   Pile Spellman, John ^a   Young, William L ^a  

^a Columbia Univ Coll Phys Surgs ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berufsgenossenschaftliche K ^*  (Germany)

^d Milstein Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY SURGERY; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ARTERIOVENOUS MALFORMATION; COST BENEFIT ANALYSIS; COST UTILITY ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; SURGICAL RISK;

ADULT; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; EMBOLIZATION, THERAPEUTIC; FEES, MEDICAL; FEMALE; HEALTH RESOURCES; HOSPITAL COSTS; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT CARE TEAM; PROGNOSIS;

EID: 0032716820     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brown RD Jr, Wiebers DO, Torner JC, O'Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted County, Minnesota. J Neurosurg 1996;85:29-32
2. Ostfeld AM. A review of stroke epidemiology. Epidemiol Rev 1980;2:136-152
3. Brown RD Jr, Wiebers DO, Forbes G, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988;68:352-357
4. Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 1983;58:331-337
5. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990;73:387-391
6. DeMeritt JS, Pile-Spellman J, Mast H, et al. Outcome analysis of preoperative embolization with N-butyl cyanoacrylate in cerebral arteriovenous malformations. AJNR Am J Neuroradiol 1995;16:1801-1807
7. Jafar JJ, Davis AJ, Berenstein A, Choi IS, Kupersmith MJ. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 1993;78:60-69
8. Pasqualin A, Scienza R, Cioffi F, et al. Treatment of cerebral arteriovenous malformations with a combination of preoperative embolization and surgery. Neurosurgery 1991;29:358-368
9. Spetzler RF, Martin NA, Carter LP, Flom RA, Raudzens PA, Wilkinson E. Surgical management of large AVM's by staged embolization and operative excision. J Neurosurg 1987;67:17-28
10. Vinuela F, Dion JE, Duckwiler G, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg 1991;75:856-864
11. Jordan JE, Marks MP, Lane B, Steinberg GK. Cost-effectiveness of endovascular therapy in the surgical management of cerebral arteriovenous malformations. AJNR Am J Neuroradiol 1996;17:247-254
12. Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery 1994;34:2-6
13. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607
14. Hartmann A, Hofmeister C, Sciacca RR, et al. Determinants of neurologic outcome after surgery for brain arteriovenous malformation. Paper presented at the annual meeting of the American Academy of Neurology, Toronto, April 1999
15. Nelson M, Bonsor G, Lamb JT. Cost implications of different policies for the treatment of arteriovenous malformations of the brain. Neuroradiology 1991;33(Suppl):203-205